Diasorin Ltd
COMPANY INFORMATION
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide range of clinical areas. DiaSorin tests are designed for hospital and private testing laboratories, in the markets of immunodiagnostics and molecular diagnostics.
LATEST STORIES
PRODUCTS AND SERVICES
Latest Issues
Nova Biomedical develops, manufactures, and sells advanced technology blood testing analyzers. We employ over 1,000 people, with sales and service subsidiaries in eight countries and distributors in more than 90 additional countries. Nova has manufacturing facilities in Waltham and Billerica, Massachusetts, Belo Horizonte, Brazil and in Taipei,...
UK NEQAS webinar: Introduction to Immunocytochemistry
Online
14-15 July, 2026
UK NEQAS webinar: Introduction to Direct Immunofluorescence
Online
16 July, 2026
IHC Antibody Recognition & Expression Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
4 August, 2026
IHC Technical Issues Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
5 August, 2026
ECP 2026 - 38th European Congress of Pathology
Stockholmsmässan, Stockholm, Sweden
12-16 September, 2026